Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Inflammatory Manifestations of Lymphedema.

Identifieur interne : 000409 ( PubMed/Curation ); précédent : 000408; suivant : 000410

Inflammatory Manifestations of Lymphedema.

Auteurs : Catherine L. Ly [États-Unis] ; Raghu P. Kataru [États-Unis] ; Babak J. Mehrara [États-Unis]

Source :

RBID : pubmed:28106728

Descripteurs français

English descriptors

Abstract

Lymphedema results from lymphatic insufficiency leading to a progressive inflammatory process that ultimately manifests as discomfort, recurrent infections, and, at times, secondary malignancy. Collectively, these morbidities contribute to an overall poor quality of life. Although there have been recent advances in microsurgical interventions, a conservative palliative approach remains the mainstay of treatment for this disabling disease. The absence of a cure is due to an incomplete understanding of the pathophysiological changes that result in lymphedema. A histological hallmark of lymphedema is inflammatory cell infiltration and recent studies with animal models and clinical biopsy specimens have suggested that this response plays a key role in the pathology of the disease. The purpose of this report is to provide an overview of the ongoing research in and the current understanding of the inflammatory manifestations of lymphedema.

DOI: 10.3390/ijms18010171
PubMed: 28106728

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:28106728

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Inflammatory Manifestations of Lymphedema.</title>
<author>
<name sortKey="Ly, Catherine L" sort="Ly, Catherine L" uniqKey="Ly C" first="Catherine L" last="Ly">Catherine L. Ly</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. lyc@mskcc.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kataru, Raghu P" sort="Kataru, Raghu P" uniqKey="Kataru R" first="Raghu P" last="Kataru">Raghu P. Kataru</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. katarur@mskcc.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Mehrara, Babak J" sort="Mehrara, Babak J" uniqKey="Mehrara B" first="Babak J" last="Mehrara">Babak J. Mehrara</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. mehrarab@mskcc.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28106728</idno>
<idno type="pmid">28106728</idno>
<idno type="doi">10.3390/ijms18010171</idno>
<idno type="wicri:Area/PubMed/Corpus">000409</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000409</idno>
<idno type="wicri:Area/PubMed/Curation">000409</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000409</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Inflammatory Manifestations of Lymphedema.</title>
<author>
<name sortKey="Ly, Catherine L" sort="Ly, Catherine L" uniqKey="Ly C" first="Catherine L" last="Ly">Catherine L. Ly</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. lyc@mskcc.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kataru, Raghu P" sort="Kataru, Raghu P" uniqKey="Kataru R" first="Raghu P" last="Kataru">Raghu P. Kataru</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. katarur@mskcc.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Mehrara, Babak J" sort="Mehrara, Babak J" uniqKey="Mehrara B" first="Babak J" last="Mehrara">Babak J. Mehrara</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. mehrarab@mskcc.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">International journal of molecular sciences</title>
<idno type="eISSN">1422-0067</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>CD4-Positive T-Lymphocytes</term>
<term>Cytokines (immunology)</term>
<term>Cytokines (metabolism)</term>
<term>Dendritic Cells</term>
<term>Disease Models, Animal</term>
<term>Humans</term>
<term>Inflammation (immunology)</term>
<term>Inflammation (metabolism)</term>
<term>Inflammation (therapy)</term>
<term>Lymphatic System (immunology)</term>
<term>Lymphatic System (metabolism)</term>
<term>Lymphatic System (pathology)</term>
<term>Lymphedema (immunology)</term>
<term>Lymphedema (metabolism)</term>
<term>Lymphedema (therapy)</term>
<term>Macrophages</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Cellules dendritiques</term>
<term>Cytokines (immunologie)</term>
<term>Cytokines (métabolisme)</term>
<term>Humains</term>
<term>Inflammation ()</term>
<term>Inflammation (immunologie)</term>
<term>Inflammation (métabolisme)</term>
<term>Lymphocytes T CD4+</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (immunologie)</term>
<term>Lymphoedème (métabolisme)</term>
<term>Macrophages</term>
<term>Modèles animaux de maladie humaine</term>
<term>Système lymphatique (anatomopathologie)</term>
<term>Système lymphatique (immunologie)</term>
<term>Système lymphatique (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Cytokines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Cytokines</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Système lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Cytokines</term>
<term>Inflammation</term>
<term>Lymphoedème</term>
<term>Système lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Inflammation</term>
<term>Lymphatic System</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Inflammation</term>
<term>Lymphatic System</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Cytokines</term>
<term>Inflammation</term>
<term>Lymphoedème</term>
<term>Système lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Lymphatic System</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Inflammation</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>CD4-Positive T-Lymphocytes</term>
<term>Dendritic Cells</term>
<term>Disease Models, Animal</term>
<term>Humans</term>
<term>Macrophages</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cellules dendritiques</term>
<term>Humains</term>
<term>Inflammation</term>
<term>Lymphocytes T CD4+</term>
<term>Lymphoedème</term>
<term>Macrophages</term>
<term>Modèles animaux de maladie humaine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Lymphedema results from lymphatic insufficiency leading to a progressive inflammatory process that ultimately manifests as discomfort, recurrent infections, and, at times, secondary malignancy. Collectively, these morbidities contribute to an overall poor quality of life. Although there have been recent advances in microsurgical interventions, a conservative palliative approach remains the mainstay of treatment for this disabling disease. The absence of a cure is due to an incomplete understanding of the pathophysiological changes that result in lymphedema. A histological hallmark of lymphedema is inflammatory cell infiltration and recent studies with animal models and clinical biopsy specimens have suggested that this response plays a key role in the pathology of the disease. The purpose of this report is to provide an overview of the ongoing research in and the current understanding of the inflammatory manifestations of lymphedema.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">28106728</PMID>
<DateCreated>
<Year>2017</Year>
<Month>01</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2017</Year>
<Month>04</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>07</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1422-0067</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>18</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2017</Year>
<Month>Jan</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>International journal of molecular sciences</Title>
<ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>Inflammatory Manifestations of Lymphedema.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">E171</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms18010171</ELocationID>
<Abstract>
<AbstractText>Lymphedema results from lymphatic insufficiency leading to a progressive inflammatory process that ultimately manifests as discomfort, recurrent infections, and, at times, secondary malignancy. Collectively, these morbidities contribute to an overall poor quality of life. Although there have been recent advances in microsurgical interventions, a conservative palliative approach remains the mainstay of treatment for this disabling disease. The absence of a cure is due to an incomplete understanding of the pathophysiological changes that result in lymphedema. A histological hallmark of lymphedema is inflammatory cell infiltration and recent studies with animal models and clinical biopsy specimens have suggested that this response plays a key role in the pathology of the disease. The purpose of this report is to provide an overview of the ongoing research in and the current understanding of the inflammatory manifestations of lymphedema.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ly</LastName>
<ForeName>Catherine L</ForeName>
<Initials>CL</Initials>
<AffiliationInfo>
<Affiliation>The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. lyc@mskcc.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kataru</LastName>
<ForeName>Raghu P</ForeName>
<Initials>RP</Initials>
<AffiliationInfo>
<Affiliation>The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. katarur@mskcc.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mehrara</LastName>
<ForeName>Babak J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>The Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. mehrarab@mskcc.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 CA008748</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 CA009501</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2017</Year>
<Month>01</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Int J Mol Sci</MedlineTA>
<NlmUniqueID>101092791</NlmUniqueID>
<ISSNLinking>1422-0067</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Commun. 2015 Feb 04;6:6196</RefSource>
<PMID Version="1">25648335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Breast Cancer Res Treat. 2013 May;139(1):81-6</RefSource>
<PMID Version="1">23613202</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2007 Sep 15;120(4):982-91</RefSource>
<PMID Version="1">17805128</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Plast Surg. 2007 Oct;59(4):464-72</RefSource>
<PMID Version="1">17901744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Immunol. 2005 Aug;5(8):617-28</RefSource>
<PMID Version="1">16056255</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bioessays. 2007 Dec;29(12):1192-202</RefSource>
<PMID Version="1">18008374</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2016 Aug;186(8):2193-203</RefSource>
<PMID Version="1">27315777</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2015 Mar;13(1):46-53</RefSource>
<PMID Version="1">25521197</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Coll Surg. 2011 Oct;213(4):543-51</RefSource>
<PMID Version="1">21802319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Plast Reconstr Surg. 2016 Sep;138(3 Suppl):209S-18S</RefSource>
<PMID Version="1">27556764</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2009 May 28;113(22):5650-9</RefSource>
<PMID Version="1">19346498</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunity. 2011 Jan 28;34(1):96-107</RefSource>
<PMID Version="1">21256057</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JCI Insight. 2016 Sep 22;1(15):e84095</RefSource>
<PMID Version="1">27699240</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Surg Oncol. 2014 Apr;21(4):1195-201</RefSource>
<PMID Version="1">24558061</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer. 2010 Nov 15;116(22):5138-49</RefSource>
<PMID Version="1">20665892</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Invest Dermatol. 2016 Mar;136(3):706-14</RefSource>
<PMID Version="1">27015456</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2012;6(5):e1655</RefSource>
<PMID Version="1">22666510</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Sci Rep. 2016 Jan 22;6:19817</RefSource>
<PMID Version="1">26796537</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphology. 1986 Dec;19(4):139-45</RefSource>
<PMID Version="1">2951567</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 2006 Jul 15;574(Pt 2):583-96</RefSource>
<PMID Version="1">16675495</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>FASEB J. 2013 Mar;27(3):1114-26</RefSource>
<PMID Version="1">23193171</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Res. 2008 Jan 15;68(2):343-5</RefSource>
<PMID Version="1">18199525</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Oncol. 2013 May;14(6):500-15</RefSource>
<PMID Version="1">23540561</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microvasc Res. 2006 Nov;72(3):161-71</RefSource>
<PMID Version="1">16876204</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(12):e52021</RefSource>
<PMID Version="1">23272198</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Reconstr Microsurg. 2016 Jan;32(1):72-9</RefSource>
<PMID Version="1">26422172</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Cell Physiol. 2011 May;300(5):C1107-21</RefSource>
<PMID Version="1">21248077</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Oncol Nurs. 2000 Aug;16(3):226-37</RefSource>
<PMID Version="1">10967795</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2011;9(3):159-67</RefSource>
<PMID Version="1">22066746</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Surg Res. 2016 Jan;200(1):208-20</RefSource>
<PMID Version="1">26235906</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Blood. 2008 May 1;111(9):4571-9</RefSource>
<PMID Version="1">18310502</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Heart Circ Physiol. 2014 May 15;306(10):H1426-34</RefSource>
<PMID Version="1">24633552</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2013 Sep;11(3):117-20</RefSource>
<PMID Version="1">24024576</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2005 Sep;115(9):2363-72</RefSource>
<PMID Version="1">16138190</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Surg Oncol. 2006 Nov;15(3):153-65</RefSource>
<PMID Version="1">17187979</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2009 Oct;175(4):1733-45</RefSource>
<PMID Version="1">19762711</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Med. 2006 Jul;3(7):e264</RefSource>
<PMID Version="1">16842020</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Crit Rev Immunol. 2012;32(6):463-88</RefSource>
<PMID Version="1">23428224</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Pathol. 2010 Dec;177(6):3202-14</RefSource>
<PMID Version="1">21056998</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 2013 Apr 15;591(8):2139-56</RefSource>
<PMID Version="1">23420659</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphology. 1990 Mar;23(1):23-33</RefSource>
<PMID Version="1">2352440</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Soc Nephrol. 2004 Mar;15(3):603-12</RefSource>
<PMID Version="1">14978162</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann N Y Acad Sci. 2008;1131:50-74</RefSource>
<PMID Version="1">18519959</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pathol. 1981 Mar;133(3):229-42</RefSource>
<PMID Version="1">7463212</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2005 Jan;115(1):56-65</RefSource>
<PMID Version="1">15630444</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Cell Physiol. 2012 Feb 15;302(4):C709-19</RefSource>
<PMID Version="1">22049214</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(11):e49940</RefSource>
<PMID Version="1">23185491</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Med. 2006 Jul;3(7):e254</RefSource>
<PMID Version="1">16834456</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2003;1(3):235-43</RefSource>
<PMID Version="1">15624440</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Physiol. 2016 Oct 15;594(20):5749-5768</RefSource>
<PMID Version="1">27219461</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>World J Surg Oncol. 2013 Jan 24;11:15</RefSource>
<PMID Version="1">23347817</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18784-9</RefSource>
<PMID Version="1">22065738</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2006;4(4):217-28</RefSource>
<PMID Version="1">17394405</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microsurgery. 2016 Sep 23;:null</RefSource>
<PMID Version="1">27661464</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Biochim Biophys Acta. 2011 May;1813(5):878-88</RefSource>
<PMID Version="1">21296109</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Semin Liver Dis. 2010 Aug;30(3):245-57</RefSource>
<PMID Version="1">20665377</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Breast. 2016 Oct;29:231-40</RefSource>
<PMID Version="1">27460425</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer. 2001 Sep 15;92(6):1368-77</RefSource>
<PMID Version="1">11745212</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Cell Biol. 2007 Jan;17(1):44-50</RefSource>
<PMID Version="1">17141502</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2113-27</RefSource>
<PMID Version="1">18849330</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphat Res Biol. 2014 Mar;12(1):10-22</RefSource>
<PMID Version="1">24502445</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2014 Dec 03;9(12):e114597</RefSource>
<PMID Version="1">25470383</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Immunol. 2012;30:531-64</RefSource>
<PMID Version="1">22224781</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JCI Insight. 2016 Oct 6;1(16):e89081</RefSource>
<PMID Version="1">27734032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Physiol Heart Circ Physiol. 2015 May 1;308(9):H1065-77</RefSource>
<PMID Version="1">25724493</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Biomark. 2010;9(1-6):531-49</RefSource>
<PMID Version="1">22112494</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2005 Sep;115(9):2316-9</RefSource>
<PMID Version="1">16138185</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Breast Cancer Res Treat. 2009 Jan;113(2):199-206</RefSource>
<PMID Version="1">18270813</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Interferon Cytokine Res. 2006 Aug;26(8):568-74</RefSource>
<PMID Version="1">16881867</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pathol. 2008 Jan;214(2):199-210</RefSource>
<PMID Version="1">18161745</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Oncol. 2016 Sep;17(9):e392-405</RefSource>
<PMID Version="1">27599144</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lymphology. 2000 Mar;33(1):19-23</RefSource>
<PMID Version="1">10769812</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Breast. 2016 Aug;28:29-36</RefSource>
<PMID Version="1">27183497</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Wiley Interdiscip Rev Dev Biol. 2016 Nov;5(6):689-710</RefSource>
<PMID Version="1">27576003</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Immunol. 2004 Aug;4(8):583-94</RefSource>
<PMID Version="1">15286725</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cardiovasc Surg (Torino). 1968 Mar-Apr;9(2):178-83</RefSource>
<PMID Version="1">5660699</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2014 Mar;124(3):936-42</RefSource>
<PMID Version="1">24590279</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2015 Jun 03;10(6):e0126908</RefSource>
<PMID Version="1">26039103</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008208" MajorTopicYN="N">Lymphatic System</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">immunity</Keyword>
<Keyword MajorTopicYN="N">inflammatory cells</Keyword>
<Keyword MajorTopicYN="N">inflammatory skin conditions</Keyword>
<Keyword MajorTopicYN="N">lymphedema</Keyword>
</KeywordList>
<CoiStatement>The authors declare no conflict of interest.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>10</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2017</Year>
<Month>01</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>01</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>1</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>1</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>4</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28106728</ArticleId>
<ArticleId IdType="pii">ijms18010171</ArticleId>
<ArticleId IdType="doi">10.3390/ijms18010171</ArticleId>
<ArticleId IdType="pmc">PMC5297803</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000409 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000409 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:28106728
   |texte=   Inflammatory Manifestations of Lymphedema.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:28106728" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024